Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test may someday predict which prostate cancer drugs will work

NCT ID NCT04662996

First seen Feb 15, 2026 · Last updated Jun 20, 2026 · Updated 16 times

Summary

This study analyzed blood samples from 33 men with advanced prostate cancer that no longer responds to hormone therapy. Researchers looked for tiny molecules called microRNAs that might predict whether a patient will resist chemotherapy or newer hormone drugs. The goal is to help doctors choose the most effective treatment from the start.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University Hospital of Tours

    Tours, 37044, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could help doctors choose the right treatment for each patient with metastatic castration-resistant prostate cancer, avoiding ineffective therapies.

What could go wrong

This was a small, observational study (33 people) that only looked for patterns in blood samples. It does not test a treatment, so it may not lead to any immediate change in care.

Conditions

The condition(s) this trial relates to.

Disease Resistance prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.